Directory

>

Frank Fang

avatar

Frank Fang

Deputy President & Head Of Precision Chemistry – G2D2 | Eisai US

Boston, Massachusetts, United States

View contact details (it's free)

Frank Fang

Summary

Frank Fang is a distinguished chemist and leader in the pharmaceutical industry, currently serving as the Deputy President and Head of Precision Chemistry at Eisai's Center for Genetics Guided Dementia Discovery (G2D2). With a strong foundation in organic chemistry, he has co-founded an interdisciplinary team focused on addressing unmet medical needs through innovative drug development. His notable achievements include the commercialization of Halaven and the discovery of E7766, showcasing his commitment to patient-centered scientific discovery. Frank holds an impressive portfolio of 56 US patents and has co-authored 33 scientific publications, reflecting his significant contributions to the field. He is also actively involved in community service, volunteering with his therapy dog, Tony. His educational background includes a PhD from Yale University and a postdoctoral fellowship at Harvard, underscoring his academic excellence. Frank's leadership experience, combined with his technical expertise, positions him as a key figure in advancing pharmaceutical science.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Frank Fang

Work Experience

company logo

Deputy President & Head Of Precision Chemistry – G2D2 at

Eisai US

January 2019 - Present

company logo

Deputy President And Head, Integrated Chemistry, Andover Innovative Medicines at

Eisai

January 2015 - January 2019

Logos provided by Logo.dev

Frank Fang

Education

Yale University, Doctor Of Philosophy - Phd

Harvard University, Nih Postdoctoral Fellow

Frequently Asked Questions about Frank Fang

What is Frank Fang email address?

Frank Fang's primary email address is **********@eisai.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Frank Fang work for?

Frank Fang is a Deputy President & Head Of Precision Chemistry – G2D2 at Eisai US, a company specializing in Biological products, except diagnostic.

Where Frank Fang graduated from?

Frank Fang holds a degree in Chemistry from University of Massachusetts Amherst.

How can I directly contact Frank Fang?

To contact Frank Fang directly, you can use the email address **********@eisai.com. Complete contact information is available upon registration with Muraena.

Who is Frank Fang?

Frank Fang is a distinguished chemist and leader in the pharmaceutical industry, currently serving as the Deputy President and Head of Precision Chemistry at Eisai's Center for Genetics Guided Dementia Discovery (G2D2). With a strong foundation in organic chemistry, he has co-founded an interdisciplinary team focused on addressing unmet medical needs through innovative drug development. His notable achievements include the commercialization of Halaven and the discovery of E7766, showcasing his commitment to patient-centered scientific discovery. Frank holds an impressive portfolio of 56 US patents and has co-authored 33 scientific publications, reflecting his significant contributions to the field. He is also actively involved in community service, volunteering with his therapy dog, Tony. His educational background includes a PhD from Yale University and a postdoctoral fellowship at Harvard, underscoring his academic excellence. Frank's leadership experience, combined with his technical expertise, positions him as a key figure in advancing pharmaceutical science.

Frank`s contact details

mail

**********@eisai.com

Colleagues

avatar
Pallavi Sachdev

Executive Director

avatar
Shawn Gallagher

President, Partnership Management Core Functional Unit

avatar
Paul Hawthorne

Executive Vice President, Purpose & Chief Business Officer

avatar
Alexander Scott

Chief Administrative Officer & Executive Vice President - Integrity

Antonia Lopresti

Executive Director. International Product Safety

avatar
Glen Wiley

Executive Director, US Payer Markets (Neurology and Oncology)

avatar
Saad Anbari Pmp

Executive Director, Statistical Programming, DHBL-CEG

avatar
Harald Hampel Md

Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs, Neurology

avatar
Susan De Santi

Executive Director, External Stakeholder Engagement, Ad, Global Medical Affairs, Nbg At Eisai Us

Susan Mayer

Executive Director, Regulatory Strategy - Oncology

View Contact details (it's free)
Request Profile Removal